Insider Trading Arrangements |
3 Months Ended | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sep. 30, 2025
shares
| |||||||||||||||||
| Trading Arrangements, by Individual | |||||||||||||||||
| Material Terms of Trading Arrangement | During the three months ended September 30, 2025, the following adopted a “Rule 10b5-1 trading arrangement” (as defined in Item 408(a) of Regulation S-K) that is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and our policies on insider trading:
(1) Date of adoption of this Rule 10b5-1 trading arrangement is in accordance with applicable SEC rules and regulations. The first trade pursuant to this Rule 10b5-1 trading arrangement will be, in accordance with applicable SEC rules and regulations, on a date after the date of adoption of the Rule 10b5-1 trading arrangement, to the extent triggered under its terms. (2) The Rule 10b5-1 trading arrangement permits transactions through and including the earlier to occur of (a) the completion of all sales or (b) the date listed in the table. |
||||||||||||||||
| Walid Abi-Saab | |||||||||||||||||
| Trading Arrangements, by Individual | |||||||||||||||||
| Name | Walid Abi-Saab | ||||||||||||||||
| Title | Chief Medical Officer | ||||||||||||||||
| Rule 10b5-1 Arrangement Adopted | true | ||||||||||||||||
| Adoption Date | September 26, 2025 | ||||||||||||||||
| Expiration Date | December 31, 2026 | ||||||||||||||||
| Aggregate Available | 105,000 | ||||||||||||||||
| Robert Gut | |||||||||||||||||
| Trading Arrangements, by Individual | |||||||||||||||||
| Name | Robert Gut | ||||||||||||||||
| Title | Non-executive Director | ||||||||||||||||
| Rule 10b5-1 Arrangement Adopted | true | ||||||||||||||||
| Adoption Date | July 8, 2025 | ||||||||||||||||
| Expiration Date | December 31, 2027 | ||||||||||||||||
| Aggregate Available | 64,599 |